Navigation Links
Jeffrey Wasserstein Joins Greenhill as Managing Director Focused on the Pharmaceutical Sector
Date:9/10/2012

NEW YORK, Sept. 10, 2012 /PRNewswire/ -- Greenhill & Co., Inc. (NYSE: GHL), a leading independent investment bank, announced today that Jeffrey Wasserstein has joined the Firm in New York to enhance its focus on the pharmaceutical sector.

Mr. Wasserstein has a 20 year history in the pharmaceutical industry in corporate development and commercial operating roles for a series of pharmaceutical companies.  Most recently he served as Senior Vice President of Business Development & Strategy at Fougera Pharmaceuticals, which was recently sold to the Sandoz division of Novartis AG.  Prior to his time at Fougera he spent five years at Dr. Reddy's Laboratories, a leading global generic pharmaceutical company, as founder and President of a branded specialty pharmaceutical subsidiary focused on dermatology as well as the Executive Vice President of North America and a member of Dr. Reddy's Global Management Council.  He began his career in the sector at Schering-Plough Corporation, where he started in a legal role and rose to first head of Corporate Business Development, then President of Schering Canada and later Senior Vice President of the parent company.  Prior to his time at Schering-Plough, he was an attorney at Wachtell, Lipton, Rosen & Katz for six years, focused on mergers and acquisitions advice.

Scott L. Bok, Chief Executive Officer of Greenhill, said, "The health care sector has become a very important part of our business, as an increasing number of companies in health care services, health care devices and pharmaceuticals have opted for our unconflicted, client-focused approach to advising clients on important transactions.  With the addition of Jeff we are significantly increasing our knowledge of the trends and opportunities in the pharmaceutical sector, as well as our access to a much larger range of companies in that sector."

Jeffrey Wasserstein said, "I am very pleased to be joining Greenhill, where I have known some of its partners for many years.  In my new role I can build upon my many relationships in the industry as well as my significant experience as a corporate development and operating executive and as an external advisor.  I look forward to utilizing my deep industry knowledge, an insider's appreciation for the many challenges facing the senior management and boards of companies in the pharmaceutical sector and my significant transaction experience to advise pharmaceutical companies on important transactions and other matters."

Greenhill & Co., Inc. is a leading independent investment bank focused on providing financial advice on significant mergers, acquisitions, restructurings, financings and capital raising to corporations, partnerships, institutions and governments.  It acts for clients located throughout the world from its offices in New York, London, Frankfurt, Stockholm, Sydney, Tokyo, Toronto, Chicago, Dallas, Houston, Los Angeles, Melbourne and San Francisco.

Contact:
Christopher T. Grubb
Chief Financial Officer
Greenhill & Co., Inc.
(212) 389-1800


'/>"/>
SOURCE Greenhill & Co., Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. AgaMatrix elects Jeffrey B. Kindler to its Board of Directors
2. Financier Jeffrey Epstein And Mount Sinai Hospital Support 3D Mammograms For Breast Cancer
3. Jeffrey Modell Foundation Opens Diagnostic Center for Primary Immunodeficiencies at Midwest Immunology Clinic
4. The Largest Private Funder Of Melanoma Research Receives Vital Support From Activist Jeffrey Epstein
5. Gerald E. Quirk Joins Choate, Hall & Stewart LLP as Co-Chair of Life Sciences Group
6. Dr. Magnus Persson Joins Cerecors Board of Directors
7. Joseph Rogers Joins SRI International as Executive Director of New Health Sciences Section in Biosciences Division
8. Pharmacy Industry Veteran Joins Millennium Pharmacy Systems as SVP Operations
9. Biotechnology Thought Leader, Dr. Abbie Celniker, Joins ImaginAb Board of Directors as Chairman
10. Dr. Gerald Yakatan Joins Imprimis Pharmaceuticals Science and Regulatory Advisory Board
11. MinuteClinic Joins with American Heart Association to Help Americans Reduce High Blood Pressure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , Feb. 23, 2017  Cogentix Medical, Inc. ... and markets innovative proprietary products for the urology market, ... fiscal year ended December 31, 2016 before the market ... The Company will host a conference call and webcast ... Thursday, March 9, 2017 at 11:00 a.m. Eastern Time ...
(Date:2/23/2017)... 23, 2017 Nevro Corp. (NYSE: NVRO), a global ... the treatment of chronic pain, today reported financial results for ... 2016 Accomplishment & Highlights: ... an increase of 228% as reported, over the prior year ... increase of 612% over the prior year ...
(Date:2/23/2017)... , 23. Februar 2017 Im Rahmen ... nationale Wirtschaftszone in der südwestlichen chinesischen Provinz Guizhou, 2017 mit ... einer Innovationsplattform aktiv an der Entwicklung einer eingebetteten Hightech-Schlüsselindustrie. ... Continue Reading ... ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... , ... The International Association of Eating Disorders Professionals (iaedp) announces the 2017 ... image mannequin art competition. Selected from 15 submissions from around the nation, the top ... 31st annual iaedp Symposium, March 22 – 26 in Las Vegas. , This year, ...
(Date:2/24/2017)... Farifax, VA (PRWEB) , ... February 24, 2017 , ... ... winners for excellence in radiology marketing programs at the annual Building Better ... the Worthington Renaissance Fort Worth Hotel in Fort Worth, Texas. Nine awards are given ...
(Date:2/24/2017)... ... February 24, 2017 , ... Congratulations ... International Elite division on February 12th. Ms. Esparza qualified into this prestigious ... qualifier competition held in Las Vegas, Nevada. Frida is one of approximately 25 ...
(Date:2/23/2017)... ... 23, 2017 , ... Thinksport, the most award-winning sunscreen on ... of Marin. For the second year in a row, cyclists will stay protected ... are thrilled to provide our safe, non-toxic sunscreen to over 2,000 cycling enthusiasts ...
(Date:2/23/2017)... ... February 23, 2017 , ... The 89th Academy Awards will be celebrated ... National Education Policy Center Bunkum Award. We invite you to enjoy our 11th annual ... Bunkum winner is the Center for American Progress (CAP), for its report, Lessons From ...
Breaking Medicine News(10 mins):